Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation.
Maurice B BizinoIngrid M JazetPaul de HeerHuub J van EykIlona A DekkersPatrick C N RensenElisabeth H M PaimanHildebrandus J LambJohannes W SmitPublished in: Diabetologia (2019)
This study was funded by Novo Nordisk A/S (Bagsvaerd, Denmark).